Final Results of a Phase 1b of Tarextumab (OMP-59R5) (anti-Notch2 3 antibody) in Combination with Nab-paclitaxel and Gemcitabine (Nab P Gem) in Patients (pts) with Untreated Metastatic Pancreatic Cancer (mPC): ALPINE Stu - Cladribine - Document - PDFSEARCH.IO

First Page	Meta Content
	Final Results of a Phase 1b of Tarextumab (OMP-59R5) (anti-Notch2/3 antibody) in Combination with Nab-paclitaxel and Gemcitabine (Nab P+Gem) in Patients (pts) with Untreated Metastatic Pancreatic Cancer (mPC): ALPINE Stu Add to Reading List Document Date: 2014-09-25 16:16:37 Open Document File Size: 874,68 KB Share Result on Facebook

Final Results of a Phase 1b of Tarextumab (OMP-59R5) (anti-Notch2/3 antibody) in Combination with Nab-paclitaxel and Gemcitabine (Nab P+Gem) in Patients (pts) with Untreated Metastatic Pancreatic Cancer (mPC): ALPINE StuAdd to Reading List